CPSA Digest 2003

Day 1

Vendor Session - Proteomics Technologies & Applications

A Flexible Asset Management Program for Proteomics Instrument Acquisition

Drug companies compress development timelines to reduce cost and shorten the time to market. Expensive analytical tools, such as a mass spectrometer (LC/MS/MS), are a large portion of the R&D instrumentation cost, which has increased by 10-fold in the last decade. McKinley Scientific asset management programs provide users with a variety of options to best acquire and utilize analytical instrumentation. Specific examples that illustrate asset management options will be discussed.

• Structure a 3 year use period with a fixed cost.
• McKinley Scientific invests in the value of the asset upfront.
• McKinley Scientific purchases 2 underutilized MS systems for $180K.
• The cost of use is reduced by 15-30% and the user is positioned for new technology.
• The user recovers an additional $180K representing 25% of original equipment cost to be reused in the budget.
• If Project or technology needs shift earlier than 3 years, the user has a partner that can maximize recovery dollars in addition to the original cost savings.

Return to Proceedings »